Stock A206650 EUBIOLOGICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/06/2024 BST 		5-day change 1st Jan Change
12,200 KRW -0.33% Intraday chart for EuBiologics Co., Ltd. -4.76% +6.36%
01-29 Zimbabwe launches door-to-door cholera vaccination campaign RE
2023 Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial CI

Business Summary

EuBiologics Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceuticals. The Company operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Biological Products and Medical Supplies
100.0 %
55,467 100.0 % 69,366 100.0 % +25.06%

Sales per region

KRW in Million2022Weight2023Weight Delta
Africa
81.3 %
29,920 53.9 % 56,422 81.3 % +88.58%
Middle East
8.6 %
5,980 10.8 % 5,932 8.6 % -0.79%
South America
3.6 %
-- 2,509 3.6 % -
South Korea
3.6 %
4,471 8.1 % 2,507 3.6 % -43.93%
Others
2.5 %
1,952 3.5 % 1,763 2.5 % -9.68%
Asia
0.3 %
13,145 23.7 % 233 0.3 % -98.23%

Managers

Managers TitleAgeSince
Yeong-Ok Baek CEO
 Chief Executive Officer 61 31/12/04
Suk-Keun Choi DFI
 Director of Finance/CFO 57 31/07/10
Kyeong-Ho Min BRD
 Director/Board Member 55 30/11/10
Byung-Ho Choi AUD
 Comptroller/Controller/Auditor 73 -
Chan-Gyu Lee PRN
 Corporate Officer/Principal 54 30/04/15
Young-Shin Park PRN
 Corporate Officer/Principal 53 31/01/11

Members of the board

Members of the board TitleAgeSince
Suk-Keun Choi DFI
 Director of Finance/CFO 57 31/07/10
Yeong-Ok Baek CEO
 Chief Executive Officer 61 31/12/04
Kyeong-Ho Min BRD
 Director/Board Member 55 30/11/10
Young-Shin Park PRN
 Corporate Officer/Principal 53 31/01/11
Duk-Sang Kim BRD
 Director/Board Member 60 -
Glenn Rockman Anthony BRD
 Director/Board Member 43 -
Seong-Muk Park BRD
 Director/Board Member 52 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 36,484,307 29,237,038 ( 80.14 %) 0 80.14 %

Shareholders

NameEquities%Valuation
Young-Sik Cho
18.52 %
6,755,133 18.52 % 66 M ₩
Wonik Investment Partners Co., Ltd.
4.461 %
1,627,659 4.461 % 16 M ₩
Duk-Sang Kim
3.881 %
1,416,060 3.881 % 14 M ₩
Yeong-Ok Baek
2.585 %
942,967 2.585 % 9 M ₩
Young-Shin Park
0.4660 %
170,000 0.4660 % 2 M ₩
Kyeong-Ho Min
0.3200 %
116,753 0.3200 % 1 M ₩
Soo-hi Jeon
0.1727 %
63,021 0.1727 % 615 849 ₩
Seok-gyu Kim
0.1568 %
57,202 0.1568 % 558 985 ₩
Chan-Gyu Lee
0.1440 %
52,552 0.1440 % 513 545 ₩
Jeong-seop Shin
0.0767 %
28,000 0.0767 % 273 620 ₩

Company contact information

EuBiologics Co., Ltd.

6/F, Bomnal-A-Chim Building 8 Mabang-ro

06778, Seoul

+

http://www.eubiologics.com
address EuBiologics Co., Ltd.(A206650)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
EUBIOLOGICS CO., LTD. Stock EuBiologics Co., Ltd.
+6.36% 320M
CSL LIMITED Stock CSL Limited
+2.22% 93.91B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-1.32% 38.4B
BIOGEN INC. Stock Biogen Inc.
-13.44% 32.61B
UCB Stock UCB
+76.30% 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.11% 15.91B
INCYTE CORPORATION Stock Incyte Corporation
+0.68% 14.22B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.06% 11.54B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+185.28% 10.74B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-53.00% 9.47B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A206650 Stock
  4. Company EuBiologics Co., Ltd.